Jinling Pharmaceutical Company Limited
SHZ: 000919.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Hai Chen
- Employees
- 5,789
- Headquarters
- Nanjing, China
- IPO year
- 1999
- Market cap
- CN¥4.5B
- Website
- https://www.jlyy000919.com
Loading 000919…
Loading profile data…Frequently asked questions about 000919
What does Jinling Pharmaceutical Company Limited (000919.SZ) do?
Jinling Pharmaceutical Company Limited manufactures and sells pharmaceutical products in China. The company offers Mailuoning injection for the treatment of thrombo-occlusive vasculitis, arteriosclerotic occlusive disease, cerebral thrombosis and sequelae, multiple arteritis, acute arterial embolism of the limbs, diabetic gangrene, venous thromb...
Where does 000919.SZ trade?
Jinling Pharmaceutical Company Limited (000919.SZ) trades on the Shenzhen Stock Exchange.
What sector is 000919.SZ in?
Jinling Pharmaceutical Company Limited (000919.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Jinling Pharmaceutical Company Limited?
Hai Chen is the chief executive officer of Jinling Pharmaceutical Company Limited (000919.SZ).
Where is Jinling Pharmaceutical Company Limited headquartered?
Jinling Pharmaceutical Company Limited is headquartered in China.
Does 000919.SZ pay a dividend?
Yes — Jinling Pharmaceutical Company Limited (000919.SZ) paid a trailing twelve-month dividend of CNY 0.10 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 000919.SZ go public?
Jinling Pharmaceutical Company Limited (000919.SZ) completed its initial public offering in 1999.